SCHEMBL21212265

SCHEMBL21212265

CN1Cc2nnccc2C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1D P48730 3/20 0.36
▸ LCK P06239 2/20 0.36
▸ MAPK8 P45983 2/20 0.36
▸ GSK3B P49841 2/20 0.36
▸ AURKB Q96GD4 2/20 0.36
▸ NUAK1 O60285 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ MAPK9 P45984 1/20 0.36
▸ CSNK1A1 P48729 1/20 0.36
▸ CSNK1E P49674 1/20 0.36
▸ MAP2K1 Q02750 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ MINK1 Q8N4C8 1/20 0.36
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ GRM5 P41594 8/20 0.34
▸ PLK4 O00444 1/20 0.31
▸ AURKA O14965 1/20 0.31
▸ CHEK2 O96017 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12059732 0.74 NPC1 (0.51) CSNK1DLCKMAPK8GSK3BAURKB
SCHEMBL26713429 0.70 CYP2C19 (0.45) KMT2AMEN1GRM5
SCHEMBL21676750 0.70 PARP1 (0.35) —
SCHEMBL24692829 0.69 GRM5 (0.38) KMT2AMEN1GRM5
SCHEMBL1674158 0.69 GRM5 (0.42) CSNK1DKMT2AMEN1GRM5
SCHEMBL29363708 0.69 GRM5 (0.42) CSNK1DKMT2AMEN1GRM5
SCHEMBL29084837 0.69 GRM5 (0.38) KMT2AMEN1GRM5
SCHEMBL29084747 0.67 BRD9 (0.40) KMT2AMEN1GRM5
SCHEMBL26141068 0.67 GRM5 (0.36) KMT2AMEN1GRM5
SCHEMBL11923831 0.67 CYP11B2 (0.41) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021121282-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS WITH IMMUNOMODULATORY FUNCTION 上海轶诺药业有限公司 2021-06-24 — — WO disclosed
EP-3831824-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) 2021-06-09 — — EP disclosed
WO-2020024997-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION 上海轶诺药业有限公司 2020-02-06 — — WO disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 — — WO disclosed
Send feedback